Miseq I100 plus system

Ended Purchase Order Awarded

Contract number
75N98026P01424
Awardee
Awarding agency
Obligated
$119,216

Award facts

Contract value 100% obligated
$119,215.62 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Cancer Institute National Institutes of Health, Department of Health and Human Services
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Jean, NV 89054, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute awarded a purchase order to Illumina, Inc. for a MiSeq i100 Plus System valued at $119,215.62 on August 26, 2026, with completion by September 26, 2026. No set-aside was used. Performance occurs at Jean, Nevada. The order is firm fixed price for a commercial sequencing instrument from the vendor's proprietary platform portfolio.

Quick answers

Who was awarded contract 75N98026P01424?

75N98026P01424 was awarded to Illumina, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on August 26, 2026.

How much is contract 75N98026P01424 worth?

The government has obligated $119,216 on 75N98026P01424.

Which agency awarded contract 75N98026P01424?

Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026P01424, with funding from National Cancer Institute (National Institutes of Health).

Was contract 75N98026P01424 competed?

The extent of competition for 75N98026P01424 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award